Latest rheumatoid arthritis Stories

2014-07-18 23:02:00

Annual conference provides groundbreaking approaches to treating patients with interrelated autoimmune conditions. Malvern, PA (PRWEB) July 18, 2014 The inaugural Interdisciplinary Autoimmune Summit (IAS) brought together more than 150 gastroenterologists, rheumatologists, dermatologists, immunologists, internists, industry, and other allied healthcare professionals at The Mirage, Las Vegas, NV, June 20-22, 2014. "IAS 2014 was a wonderful opportunity to meet and discuss best...

2014-07-16 08:28:17

PORTLAND, Ore., July 16, 2014 /PRNewswire-USNewswire/ -- Thirteen scientists received a total of $1.05 million in funding from the National Psoriasis Foundation for projects that aim to identify new treatments and a cure for psoriasis--an autoimmune disease that appears on the skin, affecting 7.5 million Americans--and psoriatic arthritis--an inflammatory arthritis that affects the joints and tendons, occurring in up to 30 percent of people with psoriasis. Learn more about the NPF research...

2014-07-15 23:08:23

In this webinar, the presenters will discuss how to leverage time response modeling to optimize clinical trial design and better predict trial outcomes for Rheumatoid Arthritis (RA) and similar indications based on a number of biologic agents that they have studied. The live broadcast will take place on Wednesday, July 23, 2014 at 10am EDT / 3pm BST (UK GMT +1). Toronto, Canada (PRWEB) July 15, 2014 Given the high medical need in this category, there has been increasing interest in recent...

2014-07-14 08:26:06

U.S. District Court for the District of Delaware Concurrently Denies Motion For Preliminary Injunction Filed by Antares Pharma, Inc. CHICAGO, July 14, 2014 /PRNewswire/ -- Medac Pharma, Inc., a privately held pharmaceutical company focused on the development of new molecules and improving the effectiveness of existing medicines, announced that the U.S. Food and Drug Administration (FDA) has approved Rasuvo(TM), a subcutaneous injectable methotrexate (MTX) therapy delivered in an auto-injector...

2014-07-10 23:09:05

Paddison Program For Rheumatoid Arthritis is a new product created by Clint Paddison and is aimed at helping people treat their rheumatoid arthritis by curing it for good. A full review of Paddison Program For Rheumatoid Arthritis on the website Vinamy.com points out whether the kit really works or not. Seattle, WA (PRWEB) July 10, 2014 Rheumatoid arthritis may be a disease that is being taken for granted in some circles, but it still is one which affects a lot of older people across all...

Low Back Pain Not Caused By The Weather
2014-07-10 03:39:33

Wiley Australian researchers reveal that sudden, acute episodes of low back pain are not linked to weather conditions such as temperature, humidity, air pressure, wind direction and precipitation. Findings published in Arthritis Care & Research, a journal of the American College of Rheumatology (ACR), indicate that the risk of low back pain slightly increases with higher wind speed or wind gusts, but was not clinically significant. According to the World Health Organization (WHO)...

2014-07-07 23:05:55

The Autoimmunity Bible & Norton Protocol is a new product created by Julia Liu and is a system designed for people suffering from and wanting to cure for good their autoimmune disorders. A complete review on the site Vinamy.com points out whether or not this program is effective. Seattle, WA (PRWEB) July 07, 2014 One of the last remaining mysteries know to modern medicine is the presence of the autoimmune disease, a blanket term applied for specific ailments which are caused by a...

2014-07-07 16:02:23

European League Against Rheumatism Low dosing of infliximab does not appear to alter treatment response or adherence Data presented today at the European League Against Rheumatism Annual Congress (EULAR 2014) showed that a significant number of patients with psoriatic arthritis (PsA) were not receiving doses of the tumour necrosis factor-alpha (TNFα) inhibitor adalimumab necessary to achieve optimal clinical benefit. Further data revealed that, in the case of the TNFα inhibitor...

2014-07-03 08:23:24

- Dermira obtains exclusive rights to develop Cimzia® in psoriasis in the US, Canada and the European Union BRUSSELS and REDWOOD CITY, Calif., July 3, 2014 /PRNewswire/ -- UCB, a global biopharmaceutical leader (Euronext: UCB), and Dermira, Inc., a privately held US-based dermatology company, announced today that they have entered into an exclusive licensing agreement for the development and future commercialization of Cimzia(®) (certolizumab pegol) in dermatology. This collaboration aims...

2014-06-30 12:26:16

NORWALK, Conn., June 30, 2014 /PRNewswire/ -- UBM Medica US announces that Rheumatology Network, a leading online community for Rheumatologists, offers special coverage of the major European rheumatology conference, just concluded in Paris, France. The annual meeting of the European Union League Against Rheumatism (EULAR) is one of the two major conferences at which rheumatologists share their latest research. Important news from this conference for the millions of people in the US with...

Word of the Day
  • A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
  • A gentle breeze; a waft; a breath.
  • Any rumor that engages general attention.
  • A cant or whining mode of speaking, especially in preaching or praying; the chant or recitative characteristic of the old Presbyterians in Scotland.
  • To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
  • To breathe in or as in sleep.
  • To utter in a whining or monotonous tone.
According to the OED, from the 16th century, this word is 'almost exclusively Scots and northern dialect until adopted in general literary use in the 19th.'